Orexo appoints Carl-Johan Blomberg CFO
This article was originally published in Scrip
Executive Summary
Carl-Johan Blomberg has joined Orexo, a pharmaceutical company focusing on developing treatments for pain and inflammation, as chief financial officer. Mr Blomberg most recently served as CFO at Micronic Mydata, and has also held financial director positions at Alfa-Laval, Procordia and Pharmacia & Upjohn.